Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000853

Type of data
NGS (scRNA-seq, TCR-seq, CITE-seq)
Access criteria
Controlled-access (Type I)
Total data volume
482 GB
File formats
  • FASTQ
Research
hum0522
Date published
2025-06-27
Date modified
2025-12-11

Analysis method

scRNA-seq

Materials and participants
Esophagogastric junction cancer (ICD10: C15.8): 2 cases
1) Blood, tumor, metastatic lymph nod, and non-metastatic lymph node: total 4 samples
2) Blood, metastatic liver cancer, and non-metastatic lymph node: total 3 samples
Gastric cancer (ICD10: C16.9): 3 cases
3) Blood, tumor, and 2 non-metastatic lymph nodes: total 4 samples
4) Blood, tumor, metastatic lymph node, and non-metastatic lymph node: total 4 samples
5) Blood, tumor, and 2 non-metastatic lymph nodes: total 4 samples
  • Health status
    Affected
  • Subject count
    19 (Sample)
Disease
Esophagogastric junction cancer (C158)
Gastric cancer (C169)
Sample description
RNAs extracted from T cells isolated from peripheral blood sample
  • Tissue
    Liver, Lymph node, Peripheral blood, Stomach
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
scRNA-seq
Target
N/A
Reagent kit
Chromium Next GEM Chip K Single Cell Kit
Chromium Next GEM Single Cell 5' v2
Fragmentation
included in the above library construction kit
Platform
Illumina NovaSeq 6000
MGI DNBSEQ-G400
Read type
Paired-end
Read length
91 bp

TCR-seq

Materials and participants
Esophagogastric junction cancer (ICD10: C15.8): 2 cases
1) Blood, tumor, metastatic lymph nod, and non-metastatic lymph node: total 4 samples
2) Blood, metastatic liver cancer, and non-metastatic lymph node: total 3 samples
Gastric cancer (ICD10: C16.9): 3 cases
3) Blood, tumor, and 2 non-metastatic lymph nodes: total 4 samples
4) Blood, tumor, metastatic lymph node, and non-metastatic lymph node: total 4 samples
5) Blood, tumor, and 2 non-metastatic lymph nodes: total 4 samples
  • Health status
    Affected
  • Subject count
    19 (Sample)
Disease
Esophagogastric junction cancer (C158)
Gastric cancer (C169)
Sample description
RNAs extracted from T cells isolated from samples
  • Tissue
    Liver, Lymph node, Peripheral blood, Stomach
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
TCR-seq
Target
N/A
Reagent kit
Chromium Next GEM Chip K Single Cell Kit
Chromium Single Cell Human TCR Amplification Kit
Fragmentation
included in the above library construction kit
Platform
Illumina NovaSeq 6000
MGI DNBSEQ-G400
Read type
Paired-end
Read length
91 bp

CITE-seq

Materials and participants
Esophagogastric junction cancer (ICD10: C15.8): 2 cases
1) Blood, tumor, metastatic lymph nod, and non-metastatic lymph node: total 4 samples
2) Blood, metastatic liver cancer, and non-metastatic lymph node: total 3 samples
Gastric cancer (ICD10: C16.9): 3 cases
3) Blood, tumor, and 2 non-metastatic lymph nodes: total 4 samples
4) Blood, tumor, metastatic lymph node, and non-metastatic lymph node: total 4 samples
5) Blood, tumor, and 2 non-metastatic lymph nodes: total 4 samples
  • Health status
    Affected
  • Subject count
    19 (Sample)
Disease
Esophagogastric junction cancer (C158)
Gastric cancer (C169)
Sample description
RNAs extracted from T cells isolated from samples
  • Tissue
    Liver, Lymph node, Peripheral blood, Stomach
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
CITE-seq
Target
N/A
Reagent kit
Chromium Next GEM Chip K Single Cell Kit
Chromium Next GEM Single Cell 5' v2
Fragmentation
included in the above library construction kit
Platform
Illumina NovaSeq 6000
MGI DNBSEQ-G400
Read type
Paired-end
Read length
91 bp